ribavirin has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banasch, M; Ellrichmann, M; Emminghaus, R; Goetze, O; Schmidt, WE | 1 |
| Breitenecker, F; Gangl, A; Kosi, L; Maresch, J; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Wrba, F | 1 |
| Antela, A; Bárcena, R; Casado, JL; Dronda, F; Moreno, A; Moreno, L; Moreno, S; Muriel, A; Navas, E; Perez-Elías, MJ; Quereda, C | 1 |
| Biglia, A; Blanco, JL; de Lazzari, E; García, F; García, M; Gatell, JM; Laguno, M; Larrousse, M; Leon, A; Loncá, M; Mallolas, J; Martínez, E; Milinkovic, A; Miró, JM; Murillas, J | 1 |
| Benhamou, Y; Sulkowski, MS | 1 |
1 review(s) available for ribavirin and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
Therapeutic issues in HIV/HCV-coinfected patients.
Topics: Anemia; Antiviral Agents; Chemical and Drug Induced Liver Injury; Disease Progression; Drug Therapy, Combination; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Liver Cirrhosis; Liver Transplantation; Mitochondrial Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2007 |
4 other study(ies) available for ribavirin and Electron Transport Chain Deficiencies, Mitochondrial
| Article | Year |
|---|---|
Longitudinal effects of hepatitis C virus treatment on hepatic mitochondrial dysfunction assessed by C-methionine breath test.
Topics: Adult; Antiviral Agents; Breath Tests; Case-Control Studies; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Function Tests; Longitudinal Studies; Male; Methionine; Middle Aged; Mitochondria, Liver; Mitochondrial Diseases; Oxidative Stress; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2008 |
Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapy.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Gene Expression Regulation; Hepacivirus; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; L-Lactate Dehydrogenase; Lactic Acid; Mitochondrial Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
High rate of didanosine-related mitochondrial toxicity in HIV/HCV-coinfected patients receiving ribavirin.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Didanosine; Female; Hepatitis C; HIV Infections; Humans; Incidence; Male; Middle Aged; Mitochondria; Mitochondrial Diseases; Proportional Hazards Models; Ribavirin | 2004 |
Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Mitochondrial Diseases; Prospective Studies; Recombinant Proteins; Ribavirin; Risk Factors | 2005 |